Mats Jerkeman, MD

Mats Jerkeman, MD, discusses essential symptoms of MCL warranting referral for earlier diagnosis.

Mats Jerkeman, MD, discusses the importance of conducting further research to classify the biological heterogeneity within MCL.

Mats Jerkeman, MD, discusses the use of induction chemoimmunotherapy followed by high-dose chemotherapy and ASCT in younger patients with MCL.